orb-lactulose syrup
orbus pharma inc - lactulose - syrup - 667mg - lactulose 667mg - ammonia detoxicants
phl-lactulose soln 667mg/ml solution
pharmel inc - lactulose - solution - 667mg - lactulose 667mg - cathartics and laxatives
pro-lactulose - 667 solution
pro doc limitee - lactulose - solution - 667mg - lactulose 667mg - ammonia detoxicants
teva-lactulose solution
teva canada limited - lactulose - solution - 667mg - lactulose 667mg - ammonia detoxicants
pms-lactulose-pharma solution
pharmascience inc - lactulose - solution - 667mg - lactulose 667mg - ammonia detoxicants
lactulose solution
chartwell rx, llc - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose is a synthetic disaccharide in solution form for oral administration. each 15 ml of lactulose solution contains: 10 g lactulose (and less than 1.6 g galactose, less than 1.2 g lactose, and 1.2 g or less of other sugars). also contains water. the ph range is 2.5 to 6.5. lactulose is a colonic acidifier which promotes laxation. the chemical name for lactulose is 4-o-β-d-galactopyranosyl-d-fructofuranose. the molecular formula is c 12 h 22 o 11 . it has the following structural formula: the molecular weight is 342.30. it is freely soluble in water.
lactulose 10g/15ml oral solution 15ml sachets sugar free unflavoured
esteve pharmaceuticals ltd - lactulose - oral solution - 666.667mg/1ml
lactulose solution
quality care products, llc - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.
enulose- lactulose solution
bryant ranch prepack - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the prevention and treatment of portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma. controlled studies have shown that lactulose solution therapy reduces the blood ammonia levels by 25 to 50%; this is generally paralleled by an improvement in the patients' mental state and by an improvement in eeg patterns. the clinical response has been observed in about 75% of patients, which is at least as satisfactory as that resulting from neomycin therapy. an increase in patients' protein tolerance is also frequently observed with lactulose therapy. in the treatment of chronic portal-systemic encephalopathy, lactulose has been given for over 2 years in controlled studies. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.
lactulose solution
sanis health inc - lactulose - solution - 667mg - lactulose 667mg - ammonia detoxicants